High-dose (40,000 IU twice/week) alpha recombinant human erythropoietin as single agent in low/intermediate risk myelodysplastic syndromes: a retrospective investigation on 133 patients treated in a single institution
| Image |  |
|---|---|
| Description | scientific article published on 01 September 2011 |
| Author/s |
author: Sara Galimberti |
| Publication date | September 1, 2011 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |